Comparing Market caps in Nash related companiesPaul is not there yet and for good reasons,,,First of all if you compare market caps you need to compare other mertics such as cash on hand ,published clinical results clinical results ,depth and duration of ongoing clinical trials etc etc
One of the slided today did compare Grinspoon study results of other Nash companies,,,This is what really counts ,,,,but comparing market caps would sound like whining about the markets and analysts getting this all wrong,,,,Paul can in one on one meetings convey that THTX is not fairly valued but the solution to change that is HIS and HIS only,,,,,,,
The markets perception of THTX casts a dark cloud on the valuation,,,Paul is very aware of this fact,,,
Thats why he needs to spend more time on selling himself ,,,,,and confirm /convibce that he is the real Mckoy.....,,Valuation will follow and at some point there will be a snowball effect
So complaining about the market not recognizing the company s valuue is not the way to fix,, things,,,,,I think Paul is well aware of the perception and he wants to change this in a professional manner and my bet is that he will succeed